252 related articles for article (PubMed ID: 18431037)
1. Pharmacological topics of bone metabolism: the physiological function of the sympathetic nervous system in modulating bone resorption.
Togari A; Arai M
J Pharmacol Sci; 2008 Apr; 106(4):542-6. PubMed ID: 18431037
[TBL] [Abstract][Full Text] [Related]
2. The role of the sympathetic nervous system in controlling bone metabolism.
Togari A; Arai M; Kondo A
Expert Opin Ther Targets; 2005 Oct; 9(5):931-40. PubMed ID: 16185149
[TBL] [Abstract][Full Text] [Related]
3. Sympathetic neural influence on bone metabolism in microgravity (Review).
Mano T; Nishimura N; Iwase S
Acta Physiol Hung; 2010 Dec; 97(4):354-61. PubMed ID: 21138811
[TBL] [Abstract][Full Text] [Related]
4. Adrenergic regulation of bone metabolism: possible involvement of sympathetic innervation of osteoblastic and osteoclastic cells.
Togari A
Microsc Res Tech; 2002 Jul; 58(2):77-84. PubMed ID: 12203706
[TBL] [Abstract][Full Text] [Related]
5. Are beta-blockers useful in the prevention of osteoporotic fractures?
Pérez-Castrillón JL; De Luis DA; Duenas-Laita A
Eur Rev Med Pharmacol Sci; 2009; 13(3):157-62. PubMed ID: 19673165
[TBL] [Abstract][Full Text] [Related]
6. [Control of bone remodeling by nervous system. Regulation of bone metabolism by peripheral nervous system].
Togari A
Clin Calcium; 2010 Dec; 20(12):1831-8. PubMed ID: 21123935
[TBL] [Abstract][Full Text] [Related]
7. Dose effects of butoxamine, a selective β2-adrenoceptor antagonist, on bone metabolism in spontaneously hypertensive rat.
Arai M; Sato T; Takeuchi S; Goto S; Togari A
Eur J Pharmacol; 2013 Feb; 701(1-3):7-13. PubMed ID: 23321373
[TBL] [Abstract][Full Text] [Related]
8. Adrenergic control of bone remodeling and its implications for the treatment of osteoporosis.
Bonnet N; Pierroz DD; Ferrari SL
J Musculoskelet Neuronal Interact; 2008; 8(2):94-104. PubMed ID: 18622078
[TBL] [Abstract][Full Text] [Related]
9. [Anabolic effects of statin and beta-blocker on bone metabolism].
Taguchi M; Takeuchi Y
Clin Calcium; 2004 Dec; 14(12):89-94. PubMed ID: 15577180
[TBL] [Abstract][Full Text] [Related]
10. The effect of beta-blockers on bone metabolism as potential drugs under investigation for osteoporosis and fracture healing.
Graham S; Hammond-Jones D; Gamie Z; Polyzois I; Tsiridis E; Tsiridis E
Expert Opin Investig Drugs; 2008 Sep; 17(9):1281-99. PubMed ID: 18694363
[TBL] [Abstract][Full Text] [Related]
11. Unloading induces osteoblastic cell suppression and osteoclastic cell activation to lead to bone loss via sympathetic nervous system.
Kondo H; Nifuji A; Takeda S; Ezura Y; Rittling SR; Denhardt DT; Nakashima K; Karsenty G; Noda M
J Biol Chem; 2005 Aug; 280(34):30192-200. PubMed ID: 15961387
[TBL] [Abstract][Full Text] [Related]
12. [Increased bone resorption by sympathetic nervous activity].
Togari A
Clin Calcium; 2006 Feb; 16(2):298-303. PubMed ID: 16465033
[TBL] [Abstract][Full Text] [Related]
13. The Role of Cannabinoids in Bone Metabolism: A New Perspective for Bone Disorders.
Saponaro F; Ferrisi R; Gado F; Polini B; Saba A; Manera C; Chiellini G
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830256
[TBL] [Abstract][Full Text] [Related]
14. A comparison between the effects of hydrophobic and hydrophilic statins on osteoclast function in vitro and ovariectomy-induced bone loss in vivo.
Hughes A; Rogers MJ; Idris AI; Crockett JC
Calcif Tissue Int; 2007 Nov; 81(5):403-13. PubMed ID: 17982704
[TBL] [Abstract][Full Text] [Related]
15. [Mechanisms of action of anticatabolic drugs used in osteoporosis therapy].
Kryśkiewicz E; Lorenc RS
Endokrynol Pol; 2009; 60(2):134-44. PubMed ID: 19396757
[TBL] [Abstract][Full Text] [Related]
16. Bi-directionally selective bone targeting delivery for anabolic and antiresorptive drugs: a novel combined therapy for osteoporosis?
Liu J; Zhang H; Dong Y; Jin Y; Hu X; Cai K; Ma J; Wu G
Med Hypotheses; 2014 Dec; 83(6):694-6. PubMed ID: 25459136
[TBL] [Abstract][Full Text] [Related]
17. Current topics in pharmacological research on bone metabolism: preface.
Furukawa K; Shinoda H
J Pharmacol Sci; 2006 Mar; 100(3):187. PubMed ID: 16518077
[No Abstract] [Full Text] [Related]
18. The osteoclast, bone remodelling and treatment of metabolic bone disease.
Boyce BF; Rosenberg E; de Papp AE; Duong LT
Eur J Clin Invest; 2012 Dec; 42(12):1332-41. PubMed ID: 22998735
[TBL] [Abstract][Full Text] [Related]
19. [Melatonin and bone status].
Ostrowska Z; Wołkowska-Pokrywa K; Kos-Kudła B; Swietochowska E; Marek B; Kajdaniuk D
Pol Merkur Lekarski; 2006 Oct; 21(124):389-93. PubMed ID: 17205785
[TBL] [Abstract][Full Text] [Related]
20. β2-Adrenergic signal transduction plays a detrimental role in subchondral bone loss of temporomandibular joint in osteoarthritis.
Jiao K; Niu LN; Li QH; Ren GT; Zhao CM; Liu YD; Tay FR; Wang MQ
Sci Rep; 2015 Jul; 5():12593. PubMed ID: 26219508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
